Insurers Should Incentivize Non-Drug Treatments for Chronic Pain
An LDI Fellow and Chronic Pain Researcher Call on Health Plans To Lower Barriers to Physical Therapy, Acupuncture, and Interdisciplinary Pain Care
Blog Post

People eligible for both Medicare and Medicaid are often dropped from Medicaid due to income changes or administrative hurdles. One potential solution, Medicare-Medicaid Plans (MMPs), was expected to increase enrollment because integrated care improves health outcomes and reduces inefficiencies for this vulnerable group.
But the first study to evaluate the effect of integrated plans on Medicaid enrollment failed to show any effect. LDI Senior Fellow Eric T. Roberts and colleagues found that the implementation of MMPs was not associated with a significant increase in Medicaid enrollment among Medicare beneficiaries living in communities with high poverty rates, where Medicaid-eligible individuals disproportionately live.
These findings suggest that the expansion of integrated care plans alone may not meaningfully increase Medicaid enrollment rates. Instead, policies that help Medicare beneficiaries retain Medicaid enrollment might better enhance Medicare-Medicaid integration efforts.
The study, “Effects of Dual-Eligible Integrated Care Plans on Medicaid Enrollment and Retention: Evidence From the Implementation of Medicare-Medicaid Plans,” was published October 2, 2025 in Medical Care Research and Review by Eric T. Roberts, Eliza Macneal, Kenton J. Johnston, José F. Figueroa.

An LDI Fellow and Chronic Pain Researcher Call on Health Plans To Lower Barriers to Physical Therapy, Acupuncture, and Interdisciplinary Pain Care
Chart of the Day: Researchers Urge Easier Renewals and Better Support To Prevent Gaps in Care
While They Wait for Medicare, People Approved for Social Security Disability Die at Higher Rates Compared to the General Public
Two Pediatricians Share Key Dates and Practical Next Steps
Medicare’s Payment Plan Can Ease Seniors’ Crushing Drug Costs but Medicare Buries it in the Fine Print
Even With Lower Prices, Medicare, Medicaid, and Other Insurers Tighten Coverage for Drugs Like Mounjaro and Zepbound Using Prior Authorization and Other Tools